Rahasia Mahjong Wins 3 Pola Gacor Profit Besar Mahjong Wins 3 Top508 Pola Bandar Terbongkar Auto Cuan Strategi Menang Mahjong Wins 3 Pola Jitu Top508 Pola Rahasia Mahjong Wins 3 Top508 Teknik Auto Profit Pola Mahjong Wins 3 2024 Trik Ampuh Raih Profit Top508 Pola Mahjong Wins 3 Top508 Buka Rahasia Bandar Menang Mudah RTP Mahjong Wins 3 Top508 Pola Bandar Paling Akurat Rahasia Menang Mahjong Wins 3 Top508 Pola Terbukti Gacor Pola Mahjong Wins 3 Top508 Terbaru untuk Profit Maksimal Strategi Mahjong Wins 3 Top508 Bocoran Pola Terbaik Rahasia Mahjong Wins 3 Pola Gacor Menang Besar Tanpa Rugi Strategi Ampuh Menang Mahjong Wins 3 Pola Jitu Top508 Pola Mahjong Wins 3 Terbaik Rahasia Sistem Bandar Top508 Terungkap Pola Mahjong Wins 3 Top508 Kalahkan Strategi Bandar Pola Mahjong Wins 3 Rahasia Sukses Menang Besar Top508 Jackpot Mahjong Wins 3 Top508 Pola Rahasia Menang Konsisten Mahjong Wins 3 Gampang Menang Pola Terbaik Pemain Pro Top508 Pola Mahjong Wins 3 Paling Gacor Rahasia Keuntungan Besar Top508 Pola Mahjong Wins 3 Paling Akurat Rahasia Auto Profit Top508 Cara Ampuh Menang Mahjong Wins 3 Pola Gacor Maximal Cuan Top508
  • pagcor slot
  • pagcor slot online
  • tol777
  • slot tol777
  • tol777
  • slot tol777
  • tol777
  • slot tol777
  • rom88
  • slot rom88
  • Why weakening of intellectual property rules is a threat to California

    Health pexels karolina grabowska 4386464

    This week, members of the World Trade Organization have convened half a world away in Abu Dhabi. But a proposal on the agenda could have profound consequences for us here in California. Representatives of the World Trade Organization’s 164 member nations will discuss whether to waive patent protections on COVID-19 tests and treatments. If California’s political leaders don’t do everything in their power to make sure that doesn’t happen, they’ll risk irrevocable damage to the state’s businesses and economy.

    This isn’t the first time the World Trade Organization has considered waiving intellectual property rights. In June 2022, member nations agreed to a patent waiver for COVID-19 vaccines. The goal was to allow developing nations to make their own generic copies of the shots — and thereby ease access to the vaccine in some of the poorest areas of the world. No country has yet taken advantage of that waiver. That’s in part because supply has never been the problem. Many developing nations don’t have the infrastructure to store, transport, and administer COVID-19 vaccines. And now, as the threat posed by SARS-CoV-2 has waned, people worldwide are less interested in getting the shot.

    Yet for some reason, developing nations are trotting out their old arguments to secure a waiver for the IP behind COVID-19 diagnostics and therapeutics. But as was the case for vaccines, there’s no evidence that intellectual property protections are holding up efforts to get these tools to people in the developing world. Indeed, the supply of tests and treatments is plentiful.

    Click to read the full article in the San Diego Union-Tribune.

    Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.

    Scroll to Top